For medium-throughput transfection of primary cells, e.g. human ADSc or MSC, when working with the 4D-Nucleofector® 96-well Unit.
For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.
For medium-throughput transfection of cell lines, e.g. Jurkat or MCF-7, when working with the 4D-Nucleofector® 96-well Unit
For medium-throughput transfection of cell lines, e.g. Jurkat or MCF-7, when working with the 4D-Nucleofector® 96-well Unit
The 21 CFR part 11 compliant software for first generation 4D-Nucleofector® Systems running under software version 4.**.
Note: For next generation 4D-Nucleofector®Systems running under software version 5.**, the corresponding LogWare is available (cat. no.: SAAF-1002, product page under development).
For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.
-
4D-Nucleofector® Protocol for PANC-1Optimized 384-well Nucleofector® and 4D-Nucleofector® Protocol for PANC-1
-
PANC-1 Transfection Protocol - 4D-Nucleofector™ X-UnitInstructions of use for transfection of PANC-1 cells with the SE Cell Line 4D-Nucleofector™ X Kit
-
PANC-1 Transfection Protocol - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of PANC-1 cells with the Cell Line Nucleofector™ Kit R
-
Lonza Bioscience Clinical Technologies – Your Trusted Partner in Regenerative Medicine
-
The Importance of Cell-subtype Selection in Creation of a 3D Liver Fibrosis ModelData sheet detailing 3D liver fibrosis model in collaboration with Visikol
-
Instructions - QCL-1000™ Assay (English)Detailed instructions for performing the QCL-1000™ Endpoint Chromogenic LAL Assay
-
Metabolism_Brochure_CoBrand_FormThis is a co-marketing form for distributors. There is a restricted space on the cover next to the Lonza logo and on the back below the market bar. Art for placement MUST be a PDF. In addition there is space on the back cover for a web address at the top and contact and disclaimers. Please look for the instruction PDF in the literature DB Article number CD-FO006Inst
-
2018 Endotoxin Testing Summit Report: Entering a New Era for Endotoxin TestingWhite Paper Report provides an update on current trends from the key stakeholders in the endotixin testing community, gives details on the key topics discussed, and looks at what the future holds for endotoxin testing.
-
Lonza - Closer Than You Think - Corporate Brochure
-
Cell Therapy Services - Your Product. Our Passion.